Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

Explore clinical trials studying Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention trial results

Completed

A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years

NCT04899336

Conditions: Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Locations: Lakeview Clinical Research Guntersville, Alabama, United States

Hope Research Institute Phoenix, Arizona, United States

Hope Research Institute Phoenix, Arizona, United States

Interspond-Clinical Research Institute of AZ Sun City West, Arizona, United States

View all 374 locations

View Trial Details

Completed

A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older

NCT06134804

Conditions: Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Locations: Medical Affiliated Research Center Inc. (MARC) Huntsville, Alabama, United States

Alliance for Multispeciality Research Mobile, Alabama, United States

Artemis Institute for Clinical Research San Diego, California, United States

Diablo Clinical Research, Inc. Walnut Creek, California, United States

View all 41 locations

View Trial Details